Immunoglobulin fusion proteins as a tool for evaluation of T-cell costimulatory molecules

被引:18
作者
Chapoval, AI [1 ]
Zhu, GF [1 ]
Chen, LP [1 ]
机构
[1] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA
关键词
fusion protein; costimulation; T lymphocytes;
D O I
10.1385/MB:21:3:259
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Costimulatory signal(s) in addition to engagement of T cell receptor is important for optimal activation of T lymphocytes. During last decade several dozens of new costimulatory molecules, including 4-1BB, CD40, OX40, CD27, and ICOS, have been identified. It is likely that in Post-Genome Era more molecules with potential costimulatory properties will be brought to our attention. We describe here a simple and reliable strategy for evaluating the functional activities of potential costimulatory molecules using soluble fusion protein between extracellular portion of costimulatory ligand and Fc portion of mouse IgG2a.
引用
收藏
页码:259 / 264
页数:6
相关论文
共 11 条
[1]  
Bluestone JA, 1996, CLIN TRANSPLANT, V10, P104
[2]   COSTIMULATION OF T-CELLS FOR TUMOR-IMMUNITY [J].
CHEN, LP ;
LINSLEY, PS ;
HELLSTROM, KE .
IMMUNOLOGY TODAY, 1993, 14 (10) :483-486
[3]   COSTIMULATION OF ANTITUMOR IMMUNITY BY THE B7 COUNTERRECEPTOR FOR THE LYMPHOCYTE-T MOLECULES CD28 AND CTLA-4 [J].
CHEN, LP ;
ASHE, S ;
BRADY, WA ;
HELLSTROM, I ;
HELLSTROM, KE ;
LEDBETTER, JA ;
MCGOWAN, P ;
LINSLEY, PS .
CELL, 1992, 71 (07) :1093-1102
[4]   Immunological ignorance of silent antigens as an explanation of tumor evasion [J].
Chen, LP .
IMMUNOLOGY TODAY, 1998, 19 (01) :27-30
[5]   New goals for the US Human Genome Project: 1998-2003 [J].
Collins, FS ;
Patrinos, A ;
Jordan, E ;
Chakravarti, A ;
Gesteland, R ;
Walters, L ;
Fearon, E ;
Hartwelt, L ;
Langley, CH ;
Mathies, RA ;
Olson, M ;
Pawson, AJ ;
Pollard, T ;
Williamson, A ;
Wold, B ;
Buetow, K ;
Branscomb, E ;
Capecchi, M ;
Church, G ;
Garner, H ;
Gibbs, RA ;
Hawkins, T ;
Hodgson, K ;
Knotek, M ;
Meisler, M ;
Rubin, GM ;
Smith, LM ;
Smith, RF ;
Westerfield, M ;
Clayton, EW ;
Fisher, NL ;
Lerman, CE ;
McInerney, JD ;
Nebo, W ;
Press, N ;
Valle, D .
SCIENCE, 1998, 282 (5389) :682-689
[6]   Artificial cell surface constructs for studying receptor-ligand contributions to lymphocyte activation [J].
Curtsinger, J ;
Deeths, MJ ;
Pease, P ;
Mescher, MF .
JOURNAL OF IMMUNOLOGICAL METHODS, 1997, 209 (01) :47-57
[7]   EFFECTIVE TUMOR VACCINE GENERATED BY FUSION OF HEPATOMA-CELLS WITH ACTIVATED B-CELLS [J].
GUO, YJ ;
WU, MC ;
CHEN, H ;
WANG, XN ;
LIU, GL ;
LI, GL ;
MA, J ;
SY, MS .
SCIENCE, 1994, 263 (5146) :518-520
[8]   Effective tumor vaccines generated by in vitro modification of tumor cells with cytokines and bispecific monoclonal antibodies [J].
Guo, YJ ;
Che, XY ;
Shen, F ;
Xie, TP ;
Ma, J ;
Wang, XN ;
Wu, SG ;
Anthony, DD ;
Wu, MC .
NATURE MEDICINE, 1997, 3 (04) :451-455
[9]   DIFFERENTIAL-EFFECTS OF ANTI-B7-1 AND ANTI-B7-2 MONOCLONAL-ANTIBODY TREATMENT ON THE DEVELOPMENT OF DIABETES IN THE NONOBESE DIABETIC MOUSE [J].
LENSCHOW, DJ ;
HO, SC ;
SATTAR, H ;
RHEE, L ;
GRAY, G ;
NABAVI, N ;
HEROLD, KC ;
BLUESTONE, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (03) :1145-1155
[10]  
Moro M, 1999, CANCER RES, V59, P2650